Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma

Published:2006-11 Issue:3 Volume:66 Page:714-720
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ma Brigette B.Y.,King Ann,Lo Y.M. Dennis,Yau Y.Y.,Zee Benny,Hui Edwin P.,Leung Sing F.,Mo Frankie,Kam Michael K.,Ahuja Anil,Kwan Wing H.,Chan Anthony T.C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference42 articles.

1. Epstein-Barr virus in the pathogenesis of NPC;Raab-Traub;Semin Cancer Biol,2002

2. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma;Pathmanathan;N Engl J Med,1995

3. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma;Lo;Cancer Res,1999

4. A phase II study of neoadjuvant taxol and carboplatin followed by concurrent cisplatin-radiotherapy in locoregionally advanced nasopharyngeal carcinoma with EBV DNA monitoring;Chan;J Clin Oncol,2004

5. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma;Lo;Ann N Y Acad Sci,2000

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection;eBioMedicine;2024-10

2. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study;Cancer Cell;2024-08

3. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

4. A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China;Scientific Reports;2023-07-20

5. Carcinoma rinofaringeo. Un tumore della testa e collo “diverso”. Parte A: dalla istologia allo staging;Acta Otorhinolaryngologica Italica;2023-04